about
Chordoma and chondrosarcoma gene profile: implications for immunotherapyPotential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathwayFrequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationIntercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcomaGlobal gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomasNuances in the treatment of malignant tumors of the clival and petroclival region.MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.Integrative analysis of neuroblastoma and pheochromocytoma genomics data.Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysisDistinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas.Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.Molecular characterization of putative chordoma cell linesThe biological basis for modern treatment of chordoma.Systemic therapy options for unresectable and metastatic chordomas.Establishment and characterization of a primary human chordoma xenograft model.An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.Multidisciplinary management of recurrent chordomas.Molecular pathology of bone tumours: diagnostic implications.The molecular aspects of chordoma.α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas.A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes.Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistanceDiscovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumoursEwing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitorsNotch activation as a driver of osteogenic sarcoma.A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic study.Patient-derived xenografts for individualized care in advanced sarcoma.Histologic and genetic advances in refining the diagnosis of "undifferentiated pleomorphic sarcoma"Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors.A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesisTransformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production.Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumorsSurvival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human diseaseDual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signalingGene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients.
P2860
Q24613307-5417F527-6E1E-4F13-B91B-65B998481B28Q24648029-952E962B-F419-41F8-AC94-0529F9BD43AEQ24651310-03F166E0-9461-4E84-AC5B-160DBE6A463DQ28284358-4060767A-09AE-46C8-BEF1-373512865E81Q28300128-A239307D-D050-4561-A6AA-43C1342CCB1DQ30411380-F646C219-E516-4B43-8935-D315DBC5E4E6Q30537249-15D44D76-9A97-4189-83AF-44EEF38BB203Q30575178-AE14136A-E7B7-4CE8-8DB2-E646E9165532Q33273190-ED4772DF-6ACC-415E-B04C-5804CEE4F777Q33273304-0D333D88-8F87-42E5-872B-4BBC514DF22CQ33273364-AE8C6176-42F8-4507-9E15-72DCECAB82ACQ33273982-649E00A0-86EE-4710-9F99-31D11F9DC919Q33274008-4047A266-A2C8-4CD3-B656-89ECAE851FDCQ33274040-B736A370-35FA-4829-95FF-E7BB93A3A691Q33274086-BCF8F23D-8BFE-4FA7-B97C-0E2C5FD51E3DQ33274146-DB20795B-54C0-43AA-9202-2C7BAE933C1EQ33274364-1C7C28C8-7E6B-44A6-8144-40AC39845FDCQ33274526-E036E54F-EB5B-4743-94AF-C73074F6F870Q33274875-E9666180-CC36-440D-91A5-FAEAC2BD1A91Q33275105-873BB7A4-BDE5-4078-913A-D4C6CB1BC6FBQ33275745-21D4FD67-C7F0-4EBB-AAFC-BA7079A46323Q33275922-4EACE771-4BDA-4339-8DFA-1A4F5B22F11CQ33515704-AE3EF2F8-C04B-4D66-B982-0C121D6601C0Q33549674-3AD0791D-6BC8-42D0-BA10-EB486057B29EQ33647672-3EA2FD64-53D6-404E-B50B-60E6192225A1Q33758070-9DAF5FF8-F052-4354-A5A1-C6DFBEDE3B39Q33808340-5877B548-C805-47B3-812E-E51563E8D9CAQ34157487-C4B74B08-DFAE-42F1-96EE-DE43EFDEA82DQ34348077-21EF7952-F35F-416F-8403-22EEC816EE66Q34413869-7F8DF156-03E4-4412-AF60-C2ACAD41FED0Q34657369-105B458A-3026-4664-9E3A-6EACFA38F859Q34729614-898E70AB-6001-4A65-B5E7-724157DA7467Q35665048-0F597531-AAFA-454A-B610-D817B4B1CF1CQ35748754-2DE7DAAF-8001-4DD1-B6CC-ED36CA191DA9Q36229623-7EFDF33F-0556-4868-B15E-815694A6B0E6Q36380337-BF95E48E-608C-4A5D-A86B-8FC6C61B682BQ36544082-CE63E391-00A7-45C8-A3F0-7C6F2A7CC6C4Q36720962-32AF95FF-0596-4DCD-BE34-1A03FD4262EAQ36888312-C4DC1710-C9A8-45A4-8FAA-6478A491CB17Q37128343-03F37A89-2D13-4E1C-BBC6-EF032BC205CA
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A molecular map of mesenchymal tumors
@nl
A molecular map of mesenchymal tumors.
@ast
A molecular map of mesenchymal tumors.
@en
type
label
A molecular map of mesenchymal tumors
@nl
A molecular map of mesenchymal tumors.
@ast
A molecular map of mesenchymal tumors.
@en
prefLabel
A molecular map of mesenchymal tumors
@nl
A molecular map of mesenchymal tumors.
@ast
A molecular map of mesenchymal tumors.
@en
P2093
P2860
P356
P1433
P1476
A molecular map of mesenchymal tumors.
@en
P2093
Adrienne M Flanagan
Chris Boshoff
David Guiliano
Jeremy Whelan
John Anderson
Nadege Presneau
Nick Athanasou
Richard Frow
Sean McLean
Sonja Vujovic
P2860
P2888
P356
10.1186/GB-2005-6-9-R76
P407
P577
2005-08-26T00:00:00Z
P5875
P6179
1006038053